neurotensin (8-13) has been researched along with dextroamphetamine in 1 studies
| Studies (neurotensin (8-13)) | Trials (neurotensin (8-13)) | Recent Studies (post-2010) (neurotensin (8-13)) | Studies (dextroamphetamine) | Trials (dextroamphetamine) | Recent Studies (post-2010) (dextroamphetamine) |
|---|---|---|---|---|---|
| 66 | 0 | 10 | 7,044 | 697 | 660 |
| Protein | Taxonomy | neurotensin (8-13) (IC50) | dextroamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dix, TA; Hadden, MK; Kokko, KP; Mazella, J; Orwig, KS | 1 |
1 other study(ies) available for neurotensin (8-13) and dextroamphetamine
| Article | Year |
|---|---|
Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Topics: Animals; Antipsychotic Agents; Area Under Curve; Arginine; Biological Availability; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Design; Haloperidol; Injections, Intraperitoneal; Lysine; Male; Motor Activity; Neurotensin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 2005 |